By substantially upregulating the expression of circRNA_0001805, ABCA1 and CPT1, GA-RM/GZ/PL can release glycyrrhizic acid to reduce the inflammatory response and play a synergistic role to protect against NAFLD-induced lipid metabolism disorder. Here, ABCA1 is linked to metabolic dysfunction-associated steatotic liver disease.